| Overview |
| bs-7683R-FITC |
| TReP132 Polyclonal Antibody, FITC Conjugated |
| IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human, Mouse, Rat, Dog, Cow, Sheep, Pig, Horse, Rabbit |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human TReP132/RAPA |
| 101-200/1200 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 55809 |
| Nucleus |
| BCAR2; Breast cancer anti estrogen resistance 2; Breast cancer anti-estrogen resistance 2; RAPA; rapa 1; rapa 2; rapa1; rapa2; RP1 139D8.5; Transcriptional regulating factor 1; Transcriptional regulating protein 132; Transcriptional-regulating factor 1; Transcriptional-regulating protein 132; TREF1_HUMAN; TReP 132; TREP132; TRERF1; Zinc finger protein rapa; Zinc finger transcription factor TReP 132; Zinc finger transcription factor TReP-132. |
| Activates transcription of CYP11A1. Interaction with CREBBP and EP300 results in a synergistic transcriptional activation of CYP11A1.Tissue specificity:Highest expression was seen in thymus, testis and adrenal cortex, expressed also in the adrenal medulla, thyroid, and stomach. Highly expressed in steroidogenic JEG-3 and MCF-7 cells, low expression was seen in non-steroidogenic HepG2 and HK293 cells. |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz